TP53 mutations in breast cancer associated with BRCA1 or BRCA2 germ-line mutations: Distinctive spectrum and structural distribution

Cancer Research

Volumn 61, Issue 10, 2001, Pages 4092-4097

  Greenblatt, Marc S ^a   Chappuis, Pierre O ^b,c   Bond, Jeffrey P ^a   Hamel, Nancy ^c   Foulkes, William D ^b,c  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

AMINO ACID TRANSPORT; ARTICLE; BREAST CANCER; CANCER SUSCEPTIBILITY; DNA BINDING; DNA DAMAGE; GENE MUTATION; GENETIC RECOMBINATION; GERM LINE; HUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; TISSUE DISTRIBUTION; TUMOR SUPPRESSOR GENE;

BINDING SITES; BRCA2 PROTEIN; BREAST NEOPLASMS; DNA; DNA MUTATIONAL ANALYSIS; FEMALE; GENES, BRCA1; GENES, P53; GERM-LINE MUTATION; HUMANS; MONTE CARLO METHOD; MUTATION, MISSENSE; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; PROTEIN STRUCTURE, SECONDARY; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0035872462     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. The genetics of breast cancer susceptibility
2. Hereditary breast cancer: Pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage
3. Pathology of familial breast cancer: Differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases
4. Clinico-pathological characteristics of BRCA1- and BRCA2-related breast cancer
5. BRCA1 expression restores radiation resistance in BRCA1-defective cancer cells through enhancement of transcription-coupled DNA repair
6. Requirement of ATM-dependent phosphorylation of BRCA1 in the DNA damage response to double-strand breaks
7. BRCA2 is required for ionizing radiation-induced assembly of rad51 complex in vivo
8. BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures
9. BRCA1 physically associates with p53 and stimulates its transcriptional activity
10. BRCA1 regulates p53-dependent gene expression
11. The second BRCT domain of BRCA1 proteins interacts with p53 and stimulates transcription from the p21WAF1/CIP1 promoter
12. Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumor formation
13. Molecular genetic characterization of BRCA1- and BRCA2-linked hereditary ovarian cancers
14. Computer program for the analysis of mutational spectra: Application to p53 mutations
15. Somatic point mutations in the p53 gene of human tumors and cell lines: Updated compilation
16. Crystal structure of a p53 tumor suppressor-DNA complex: Understanding tumorigenic mutations
17. Evolutionary conservation and somatic mutation hotspot maps of p53: Correlation with p53 protein structural and functional features
18. p53 mutation with frequent novel codons but not a mutator phenotype in BRCA1- and BRCA2-associated breast tumors
19. BRCA2 and p53 mutations in primary breast cancer in relation to genetic instability
20. Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: A population-based study
21. Frequency of p53 mutations in breast carcinomas from Ashkenazi Jewish carriers of BRCA1 mutations
22. Accumulation of p53 protein is frequent in ovarian cancers associated with BRCA1 and BRCA2 germline mutations
23. Increased frequency of TP53 mutations in BRCA1 and BRCA2 ovarian tumors
24. Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis
25. Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells
26. Novel p53 mutants selected in BRCA-associated tumors which dissociate transformation suppression from other wild-type p53 functions
27. In search of the tumour-suppressor functions of BRCA1 and BRCA2
28. Molecular nature of colon tumors in hereditary nonpolyposis colon cancer, familial polyposis, and sporadic colon cancer
29. Replication error in human breast cancer: Comparison with clinical variables and family history of cancer
30. Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas
31. Specific p53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients
32. Heterogeneity in the clinical phenotype of TP53 mutations in breast cancer patients